{"id":59999,"date":"2015-09-18T08:00:38","date_gmt":"2015-09-18T12:00:38","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=59999"},"modified":"2015-09-26T09:15:36","modified_gmt":"2015-09-26T13:15:36","slug":"an-innovative-design","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2015\/09\/18\/an-innovative-design\/","title":{"rendered":"an innovative design&#8230;"},"content":{"rendered":"<div align=\"justify\" class=\"small\">It has been quite a week, so I haven&#8217;t had much else on my mind outside of our own publication [<a href=\"http:\/\/www.bmj.com\/cgi\/doi\/10.1136\/bmj.h4320\" target=\"_blank\">Restoring   Study 329: efficacy and harms of paroxetine and                 imipramine in treatment of major depression in adolescence<\/a>], but I ran across this paper and thought it was pretty interesting &#8211; focused on a topic that&#8217;s close to what we were writing about:     <\/div>\n<blockquote>\n<div align=\"center\" class=\"big\"><a href=\"http:\/\/journals.plos.org\/plosmedicine\/article?id=10.1371\/journal.pmed.1001875\" target=\"_blank\">Selective Serotonin Reuptake Inhibitors and Violent Crime: A Cohort Study<\/a><\/div>\n<div align=\"center\" class=\"big\"><strong><font color=\"#891fb1\">PLoS Medicine<\/font><\/strong><\/div>\n<div align=\"center\" class=\"middle\">by Yasmina Molero, Paul Lichtenstein, Johan Zetterqvist, Clara Hellner Gumpert, and Seena Fazel<\/div>\n<div align=\"center\" class=\"small\">September 15, 2015<\/div>\n<div align=\"center\" class=\"middle\">[<a href=\"http:\/\/journals.plos.org\/plosmedicine\/article?id=10.1371\/journal.pmed.1001875\" target=\"_blank\">full text on-line]<\/a><\/div>\n<p>              <\/p>\n<div align=\"justify\"><u><strong><font color=\"#200020\">Background<\/font><\/strong><\/u>: Although selective serotonin reuptake inhibitors [SSRIs] are widely prescribed, associations with violence are uncertain.<\/div>\n<div align=\"justify\"><u><strong><font color=\"#200020\">Methods and Findings<\/font><\/strong><\/u>: From Swedish national registers we extracted information on 856,493 individuals who were prescribed SSRIs, and subsequent violent crimes during 2006 through 2009. We used stratified Cox regression analyses to compare the rate of violent crime while individuals were prescribed these medications with the rate in the same individuals while not receiving medication. Adjustments were made for other psychotropic medications. Information on all medications was extracted from the Swedish Prescribed Drug Register, with complete national data on all dispensed medications. Information on violent crime convictions was extracted from the Swedish national crime register. Using within-individual models, there was an overall association between SSRIs and violent crime convictions [hazard ratio [HR] = 1.19, 95% CI 1.08&ndash;1.32, p &lt; 0.001, absolute risk = 1.0%]. With age stratification, there was a significant association between SSRIs and violent crime convictions for individuals aged 15 to 24 y [HR = 1.43, 95% CI 1.19&ndash;1.73, p &lt; 0.001, absolute risk = 3.0%]. However, there were no significant associations in those aged 25&ndash;34 y [HR = 1.20, 95% CI 0.95&ndash;1.52, p = 0.125, absolute risk = 1.6%], in those aged 35&ndash;44 y [HR = 1.06, 95% CI 0.83&ndash;1.35, p = 0.666, absolute risk = 1.2%], or in those aged 45 y or older [HR = 1.07, 95% CI 0.84&ndash;1.35, p = 0.594, absolute risk = 0.3%]. Associations in those aged 15 to 24 y were also found for violent crime arrests with preliminary investigations [HR = 1.28, 95% CI 1.16&ndash;1.41, p &lt; 0.001], non-violent crime convictions [HR = 1.22, 95% CI 1.10&ndash;1.34, p &lt; 0.001], non-violent crime arrests [HR = 1.13, 95% CI 1.07&ndash;1.20, p &lt; 0.001], non-fatal injuries from accidents [HR = 1.29, 95% CI 1.22&ndash;1.36, p &lt; 0.001], and emergency inpatient or outpatient treatment for alcohol intoxication or misuse [HR = 1.98, 95% CI 1.76&ndash;2.21, p &lt; 0.001]. With age and sex stratification, there was a significant association between SSRIs and violent crime convictions for males aged 15 to 24 y [HR = 1.40, 95% CI 1.13&ndash;1.73, p = 0.002] and females aged 15 to 24 y [HR = 1.75, 95% CI 1.08&ndash;2.84, p = 0.023]. However, there were no significant associations in those aged 25 y or older. One important limitation is that we were unable to fully account for time-varying factors. <\/div>\n<div align=\"justify\"><u><strong><font color=\"#200020\">Conclusions<\/font><\/strong><\/u>: The association between SSRIs and violent crime convictions and violent crime arrests varied by age group. The increased risk we found in young people needs validation in other studies.<\/div>\n<p>       <\/p>\n<div align=\"center\"><img loading=\"lazy\" decoding=\"async\" width=\"400\" height=\"275\" border=\"0\" src=\"http:\/\/1boringoldman.com\/images\/plos-med.jpg\" \/><br \/>    [cropped to fit the space]<\/div>\n<\/blockquote>\n<div align=\"justify\" class=\"small\">Scandanavia has always been a special place for medical epidemiology. The countries are isolated, self contained, and they have centralized and detailed record keeping going back to the dawn of time. If you&#8217;re looking for twins adopted to different families at birth to look at nature vs nurture, head for Scandanavia. This is one of those studies &#8211; a Sweden-wide three year look at the relationship between taking SSRIs and violence. But there&#8217;s something more. They used the subjects themselves as their own controls [which struck me as a really bright thought].      <\/div>\n<p align=\"justify\" class=\"small\">Besides having access a cohort of 8+M people [~10% on SSRIs] with their prescription records and the public records of every brush with the law, they had some mighty fine computers and statisticians to have extracted their data and cross-checked so many covariates. I couldn&#8217;t possibly&quot;vet&quot; all of their analyses. But the core thread is that they isolated periods when patients were &quot;on&quot; SSRIs and when they were &quot;off&quot; the medication, and they compared the arrest rates for violent crimes &quot;on&quot; and &quot;off&quot; &#8211; deriving a <a target=\"_blank\" href=\"https:\/\/en.wikipedia.org\/wiki\/Hazard_ratio\">Hazard Ratio<\/a>.  <\/p>\n<div align=\"justify\" class=\"small\">While the paper deserves a careful reading, it feels like they&#8217;ve done their due diligence. There have been a ton of papers that have tried to debunk the black box warning of aggressive behavior in some adolescents on these SSRIs &#8211; and many of them focus on population studies:  <\/div>\n<ol><sup>          <\/p>\n<li>\n<div align=\"justify\"><a target=\"_blank\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15699293\">The relationship between antidepressant               medication use and rate of suicide.<\/a><\/div>\n<div align=\"justify\">Gibbons RD, Hur K, Bhaumik DK, Mann JJ.<\/div>\n<div align=\"justify\">Arch Gen Psychiatry. 2005             Feb;62(2):165-72.<\/div>\n<\/li>\n<li>\n<div align=\"justify\"><a target=\"_blank\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17074941\">The relationship between antidepressant               prescription rates and rate of early adolescent suicide.<\/a><\/div>\n<div align=\"justify\">Gibbons RD, Hur K, Bhaumik DK, Mann JJ.<\/div>\n<div align=\"justify\">Am J Psychiatry. 2006             Nov;163(11):1898-904.<\/div>\n<\/li>\n<li>\n<div align=\"justify\"><a href=\"http:\/\/archpsyc.ama-assn.org\/cgi\/content\/full\/64\/4\/466\" target=\"_blank\">Impact of               Publicity Concerning Pediatric Suicidality Data on               Physician Practice Patterns in the United States<\/a><\/div>\n<div align=\"justify\">Charles B. Nemeroff, Amir Kalali, Martin             B. Keller, Dennis S. Charney, Susan E. Lenderts, Elisa F.             Cascade, Hugo Stephenson, and Alan F. Schatzberg<\/div>\n<div align=\"justify\">Arch Gen Psychiatry. 2007             Apr;64(4):466-472.<\/div>\n<\/li>\n<li>\n<div align=\"justify\"><a target=\"_blank\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17592916\">Association of suicide and antidepressant               prescription rates in Japan, 1999-2003.<\/a><\/div>\n<div align=\"justify\">Nakagawa A, Grunebaum MF, Ellis SP,             Oquendo MA, Kashima H, Gibbons RD, Mann JJ.<\/div>\n<div align=\"justify\">J Clin Psychiatry. 2007             Jun;68(6):908-916.<\/div>\n<\/li>\n<li>\n<div align=\"justify\"><a target=\"_blank\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17606833\">Effect of Regulatory Warnings on               Antidepressant Prescribing for Children and Adolescents.<\/a><\/div>\n<div align=\"justify\">Benji T. Kurian, MD, MPH; Wayne A. Ray,             PhD; Patrick G. Arbogast, PhD; D. Catherine Fuchs, MD;             Judith A. Dudley, BS; William O. Cooper, MD, MPH<\/div>\n<div align=\"justify\">JAMA: Pediatrics. 2007             Jun;161(7):690-696.<\/div>\n<div align=\"justify\"><a target=\"_blank\" href=\"http:\/\/archpedi.jamanetwork.com\/article.aspx?articleid=570753\">[full text online]<\/a><\/div>\n<\/li>\n<li>\n<div align=\"justify\"><a target=\"_blank\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17606656\">Relationship between antidepressants and               suicide attempts: an analysis of the Veterans Health               Administration data sets.<\/a><\/div>\n<div align=\"justify\">Gibbons RD, Brown CH, Hur K, Marcus SM,             Bhaumik DK, Mann JJ.<\/div>\n<div align=\"justify\">Am J Psychiatry. 2007             Jul;164(7):1044-1049.<\/div>\n<\/li>\n<li>\n<div align=\"justify\"><a target=\"_blank\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17728420\">Early evidence on the effects of               regulators&#8217; suicidality warnings on SSRI prescriptions and               suicide in children and adolescents.<\/a> [see <a href=\"http:\/\/1boringoldman.com\/index.php\/2011\/10\/27\/peaks-and-valleys\" target=\"_blank\">peaks                and valleys&hellip;<\/a>]<\/div>\n<div align=\"justify\">Gibbons RD, Brown CH, Hur K, Marcus SM,             Bhaumik DK, Erkens JA, Herings RM, Mann JJ.<\/div>\n<div align=\"justify\">Am J Psychiatry. 2007             Sep;164(9):1356-1363.<\/div>\n<\/li>\n<li>\n<div align=\"justify\"><a target=\"_blank\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18092240\">The role of randomized trials in testing               interventions for the prevention of youth suicide.<\/a><\/div>\n<div align=\"justify\">Brown CH, Wyman PA, Brinales JM, Gibbons             RD.<\/div>\n<div align=\"justify\">Int Rev Psychiatry. 2007             Dec;19(6):617-631.<\/div>\n<\/li>\n<li>\n<div align=\"justify\"><a target=\"_blank\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18404622\">Mixed-effects Poisson regression analysis               of adverse event reports: the relationship between               antidepressants and suicide.<\/a><\/div>\n<div align=\"justify\">Gibbons RD, Segawa E, Karabatsos G,             Amatya AK, Bhaumik DK, Brown CH, Kapur K, Marcus SM, Hur K,             Mann JJ.<\/div>\n<div align=\"justify\">Stat Med. 2008 May 20;27(11):1814-1833.<\/div>\n<\/li>\n<li>\n<div align=\"justify\"><a href=\"http:\/\/pediatrics.aappublications.org\/content\/125\/1\/88.long\" target=\"_blank\">News               coverage of FDA warnings on pediatric antidepressant use               and suicidality<\/a><\/div>\n<div align=\"justify\">Barry CL and Busch SH.<\/div>\n<div align=\"justify\">Pediatrics. 2010 125[1]:88-95.<\/div>\n<div align=\"justify\">[<a href=\"http:\/\/pediatrics.aappublications.org\/content\/125\/1\/88.long\" target=\"_blank\">full                text online<\/a>]<\/div>\n<\/li>\n<li>\n<div align=\"justify\"><a target=\"_blank\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21513361\">Strategies for quantifying the               relationship between medications and suicidal behaviour:               what has been learned?<\/a><\/div>\n<div align=\"justify\">Gibbons RD, Mann JJ.<\/div>\n<div align=\"justify\">Drug Saf. 2011 May 1;34(5):375-395.<\/div>\n<\/li>\n<li>\n<div align=\"justify\"><a target=\"_blank\" href=\"http:\/\/www.nber.org\/papers\/w17426.pdf\">THE FDA AND ABCS: THE UNINTENDED               CONSEQUENCES OF ANTIDEPRESSANT WARNINGS ON HUMAN CAPITAL<\/a><\/div>\n<div align=\"justify\">Susan Busch, Ezra Golberstein, Ellen             Meara<\/div>\n<div align=\"justify\">NATIONAL BUREAU OF ECONOMIC RESEARCH,             September 2011.<\/div>\n<\/li>\n<li>\n<div align=\"justify\"><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22309973\" target=\"_blank\">Suicidal                Thoughts and Behavior With Antidepressant Treatment:               Reanalysis of the Randomized Placebo-Controlled Studies of               Fluoxetine and Venlafaxine<\/a><\/div>\n<div align=\"justify\">Robert D. Gibbons, Hendricks Brown, Kwan             Hur, John M. Davis, and J. John Mann<\/div>\n<div align=\"justify\">Arch Gen Psychiatry. 2012             Jun;69(6):580-587.<\/div>\n<\/li>\n<li>\n<div align=\"justify\"><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25263479\" target=\"_blank\">Antidepressant                treatment and suicide attempts and self-inflicted injury               in children and adolescents<\/a><\/div>\n<div align=\"justify\">Gibbons RD, Coca Perraillon M, Hur K,             Conti RM, Valuck RJ, and Brent DA<\/div>\n<div align=\"justify\">Pharmacoepidemiologic Drug Safety. 2014             Sep 29. doi: 10.1002\/pds.3713. [Epub ahead of print] <\/div>\n<\/li>\n<li>\n<div align=\"justify\"><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24942789\" target=\"_blank\">Changes               in antidepressant use by young people and suicidal               behavior after FDA warnings and media coverage:               quasi-experimental study<\/a><\/div>\n<div align=\"justify\">Christine Y Lu, Fang Zhang , Matthew D             Lakoma analyst, Jeanne M Madden, Donna Rusinak, Robert B             Penfold, Gregory Simon, Brian K Ahmedani, Gregory Clarke,             Enid M Hunkeler, Beth Waitzfelder, Ashli Owen-Smith, Marsha             A Raebel, Rebecca Rossom, Karen J Coleman, Laurel A             Copeland, Stephen B Soumerai<\/div>\n<div align=\"justify\">BMJ. 2014 348:g3596.<\/div>\n<div align=\"justify\">[<a href=\"http:\/\/www.bmj.com\/content\/348\/bmj.g3596\" target=\"_blank\">full text               online<\/a>]<\/div>\n<\/li>\n<li>\n<div align=\"justify\"><a href=\"http:\/\/psychnews.psychiatryonline.org\/doi\/full\/10.1176\/appi.pn.2014.11b1B\" target=\"_blank\">FDA                Actions on Antidepressants and Suicidality: 10 Years Later<\/a><\/div>\n<div align=\"justify\"><font color=\"#100000\">PSYCHIATRIC<\/font><font color=\"#990000\">NEWS<\/font><\/div>\n<div align=\"justify\">by Mark Moran<\/div>\n<div align=\"justify\">12\/30\/2014<\/div>\n<div align=\"justify\">[<a href=\"http:\/\/psychnews.psychiatryonline.org\/doi\/full\/10.1176\/appi.pn.2014.11b1B\" target=\"_blank\">full                text on-line<\/a>]<\/div>\n<\/li>\n<li>\n<div align=\"justify\"><a target=\"_blank\" href=\"http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMp1408480#t=article\">Antidepressants&rsquo; Black-Box Warning <\/a><\/div>\n<div align=\"justify\"><a target=\"_blank\" href=\"http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMp1408480#t=article\"> &ndash; 10 Years Later<\/a><\/div>\n<div align=\"justify\">by Richard A. Friedman, M.D.<\/div>\n<div align=\"justify\"><font color=\"#200020\">New England Journal               of Medicine<\/font> 2014 371:1666-1668.<\/div>\n<div align=\"justify\">[<a target=\"_blank\" href=\"http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMp1408480#t=article\">full text on-line<\/a>]<\/div>\n<\/li>\n<li>\n<div align=\"justify\"><a target=\"_blank\" href=\"http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMp1411138\">The FDA Warning on Antidepressants and               Suicidality<\/a><br \/>              <a target=\"_blank\" href=\"http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMp1411138\"> &ndash; Why the Controversy?<\/a><\/div>\n<div align=\"justify\">by Marc B. Stone, M.D.<\/div>\n<div align=\"justify\"><font color=\"#200020\">New England Journal               of Medicine<\/font> 2014 371:1668-1671.<\/div>\n<div align=\"justify\">[<a target=\"_blank\" href=\"http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMp1411138\">full text on-line<\/a>]<\/div>\n<\/li>\n<li>\n<div align=\"justify\"><a target=\"_blank\" href=\"http:\/\/www.nytimes.com\/2015\/08\/03\/opinion\/teenagers-medication-and-suicide.html?smid=tw-NYTHealth&#038;seid=auto&#038;_r=0\">Teenagers, Medication and Suicide<\/a><\/div>\n<div align=\"justify\"><font color=\"#000001\">New York Times<\/font><\/div>\n<div align=\"justify\">by Richard A. Friedman<\/div>\n<div align=\"justify\">AUGUST 3, 2015<\/div>\n<\/li>\n<p>        <\/sup><\/ol>\n<div align=\"justify\" class=\"small\">While I&#8217;ll readily admit that&nbsp; the findings in this Swedish study fit my own ideas about this topic, I&#8217;m impressed that they did a good job in bringing an innovative design using objective measures to bear on the problem. I think it&#8217;s a study well worth looking into in more depth. Most of the articles in the list above start with a conclusion and then try to validate it [in my humble opinion]&#8230;<\/div>\n","protected":false},"excerpt":{"rendered":"<p>It has been quite a week, so I haven&#8217;t had much else on my mind outside of our own publication [Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence], but I ran across this paper and thought it was pretty interesting &#8211; focused on a topic that&#8217;s [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[5],"tags":[],"class_list":["post-59999","post","type-post","status-publish","format-standard","hentry","category-opinion"],"_links":{"self":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/59999","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/comments?post=59999"}],"version-history":[{"count":21,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/59999\/revisions"}],"predecessor-version":[{"id":60221,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/59999\/revisions\/60221"}],"wp:attachment":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/media?parent=59999"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/categories?post=59999"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/tags?post=59999"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}